Free Trial

CASI Pharmaceuticals (CASI) News Today

$5.46
-0.07 (-1.27%)
(As of 10/3/2024 ET)
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average of $4.67
CASI Pharmaceuticals (NASDAQ:CASI) Shares Cross Above Two Hundred Day Moving Average of $4.67
BioInvent International AB (BIX0.DU)
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.60
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Passes Above 200 Day Moving Average of $4.60
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above 200 Day Moving Average of $4.57
CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200 Day Moving Average of $4.57
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Update
CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the target of a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 172,000 shares, a drop of 15.1% from the July 31st total of 202,600 shares. Based on an average trading volume of 240,300 shares, the days-to-cover ratio is presently 0.7 days. Approximately 4.0% of the company's shares are sold short.
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.46
CASI Pharmaceuticals (NASDAQ:CASI) Shares Cross Above 200 Day Moving Average of $4.46
CASI Pharmaceuticals, Inc. stock logo
Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 6.9%
CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totalling 202,600 shares, a decrease of 6.9% from the July 15th total of 217,600 shares. Currently, 3.2% of the company's stock are short sold. Based on an average daily volume of 240,500 shares, the days-to-cover ratio is presently 0.8 days.
CASI Pharmaceuticals, Inc. Q2 Loss Declines
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above Two Hundred Day Moving Average of $4.47
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above 200 Day Moving Average of $4.47
Ligand Reports Second Quarter 2024 Financial Results
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.44
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Passes Above Two Hundred Day Moving Average of $4.44
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of CASI Pharmaceuticals in a report on Saturday. They set a "hold" rating for the company.
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200 Day Moving Average of $4.41
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above 200-Day Moving Average of $4.41
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of CASI Pharmaceuticals in a research report on Friday. They set a "hold" rating on the stock.
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Up 771.1% in June
CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 529,600 shares, an increase of 771.1% from the June 15th total of 60,800 shares. Currently, 8.2% of the company's stock are short sold. Based on an average daily trading volume, of 231,700 shares, the short-interest ratio is currently 2.3 days.
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.42
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Passes Above 200 Day Moving Average of $4.42
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Down 23.7% in June
CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 60,800 shares, a drop of 23.7% from the May 31st total of 79,700 shares. Approximately 0.9% of the shares of the company are sold short. Based on an average daily volume of 53,800 shares, the short-interest ratio is currently 1.1 days.
CASI Pharmaceuticals, Inc. stock logo
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Sees Significant Increase in Short Interest
CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 53,100 shares, a growth of 14.7% from the April 30th total of 46,300 shares. Based on an average trading volume of 193,200 shares, the short-interest ratio is currently 0.3 days. Currently, 0.8% of the company's shares are short sold.
CASI Pharmaceuticals, Inc. (CASI)
CASI Pharmaceuticals updates on Juventas dispute
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Apr 2024 2.500 call
CASI Mar 2024 10.000 call
CASI Mar 2024 7.500 put
Get CASI Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter.

44-year Wall Street Vet: “Permanent devastation is coming to America” (Ad)

After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. But now a looming disaster is threatening America. And it's unlike anything we've ever experienced before.

The information in this video is crucially valuable.

CASI Media Mentions By Week

CASI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CASI
News Sentiment

0.38

0.58

Average
Medical
News Sentiment

CASI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CASI Articles
This Week

3

1

CASI Articles
Average Week

Get CASI Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CASI) was last updated on 10/3/2024 by MarketBeat.com Staff
From Our Partners